Commonwealth Equity Services, LLC Infla Rx N.V. Transaction History
Commonwealth Equity Services, LLC
- $75.7 Billion
- Q2 2025
A detailed history of Commonwealth Equity Services, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 144,000 shares of IFRX stock, worth $119,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144,000
Previous 106,500
35.21%
Holding current value
$119,520
Previous $109,000
4.59%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IFRX
# of Institutions
32Shares Held
17.5MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$5.38 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$2.05 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$1.64 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$1.36 Million0.13% of portfolio
-
Woodline Partners LP San Francisco, CA751KShares$623,5510.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $36.7M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...